A one hour class linking DEA’s, FDA’s and SAMHSA ’s authority as it relates to MAT along with national studies, risk mitigation strategies, patient limits, criminal and civil case studies, emerging issues, urine drug screens, common FAQ’s, law enforcement & provider partnerships, and preparing for a DEA audit. The goal of the course is to alleviate provider concerns regarding DEA relative to MAT.